4Center for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States,2003. Reved[ M]. Atlanta: US Department of Health and Human service, Center for Disease Control and Prevention, 2004.
5Collins A J, Kasiske B, Herzog C, et al. United States renal data system 2006 annual data report abstract[J]. Am J Kidney Dis, 2007,49( 1 Suppl 1 ) : A6 - 7.
6Ng DP,Placha G,Choo S,et al. Adisease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus [ J ]. Diabetes, 2006,55:2660 - 2663.
7Shestakova MV,Vikulova OK,Gorashko NM,et al. The relationship between genetic and haemodynamic factors in diabetic nephropathy (DN) :Case control study in type 1 diabetes mellitus(TIDM) [J]. Diabetes ReClin Pract ,2006,74(2Suppl ) : S41 - S50.
8Mollsten A, Wessman M, Svensson M, ct al. Glu298 Asp and NOS4 apolymorphisms in diabetic nephropathy [ J ]. Ann Med, 2006,38:522 - 528.
9Ng MC, Baum L,So WY, et al. Association of lipoprotein lipase S447X, apolipoprotein Eexon4, and apo C32455 T > C polymorphisms on the susceptibility to diabetic nephropathy [J]. Clin Genet ,2006,70:20 - 28.
10BAYAT A, BOCK Q, MROWIETZu, et al. Genetic susceptibility to Keloid disease and hypertrophic scarring transforming growth factor beta 1 common polymorphisma and plasma levels[J]. Plast Reconstr Surg, 2003,111:534 -543.
